Baojian Wei

Dr. Baojian Wei


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2024 in International Journal of Surgery
Verified
Journal Article
Open access
HZHongyu Zhang
Hongyu Zhang
LJLe Jiao
Le Jiao
SYSongxiang Yang
Songxiang Yang
HLHaopeng Li
Haopeng Li
XJXinZhan Jiang
XinZhan Jiang
BWBaojian Wei
Baojian Wei
Neurological disorders such as Parkinson’s disease, stroke, and spinal cord injury can result in impairments of motor function, consciousness, cognition, and sensory processing. Brain-Computer Interface (BCI) technology, which facilitates direct communication between the brain and external devices, emerges as an innovative key to unlocking neurological conditions, demonstrating significant promise in this context. This comprehensive review uniquely synthesizes the latest advancements in BCI research across multiple neurological disorders, offering an interdisciplinary perspective on both clinical applications and emerging technologies. We explore the progress in BCI research and its applications in addressing various neurological conditions, with a particular focus on recent clinical studies and prospective developments. Initially, the review provides an up-to-date overview of BCI technology, encompassing its classification, operational principles, and prevalent paradigms. It then critically examines specific BCI applications in movement disorders, disorders of consciousness, cognitive and mental disorders, as well as sensory disorders, highlighting novel approaches and their potential impact on patient care. This review reveals emerging trends in BCI applications, such as the integration of artificial intelligence and the development of closed-loop systems, which represent significant advancements over previous technologies. The review concludes by discussing the prospects and directions of BCI technology, underscoring the need for interdisciplinary collaboration and ethical considerations. It emphasizes the importance of prioritizing bidirectional and high-performance BCIs, areas that have been underexplored in previous reviews. Additionally, we identify crucial gaps in current research, particularly in long-term clinical efficacy and the need for standardized protocols. The role of neurosurgery in spearheading the clinical translation of BCI research is highlighted. Our comprehensive analysis presents BCI technology as an innovative key to unlocking neurological disorders, offering a transformative approach to diagnosing, treating, and rehabilitating neurological conditions, with substantial potential to enhance patients’ quality of life and advance the field of neurotechnology. Export

20 September 2023 in Frontiers in Public Health
Verified
Journal Article
Open access
YHYang He
Yang He
BWBaojian Wei
Baojian Wei
YLYushang Li
Yushang Li
Background: The rapid population aging in China, characterized by a higher prevalence of illnesses, earlier onset of diseases, and longer durations of living with ailments, substantially engenders challenges within the domain of older adults’ healthcare. Community home-based elderly care services (CHECS) are a feasible solution to solve the problem of older adults’ care and protect older adults’ health. The aim of this study is to investigate the relationship, heterogeneity effects and influential mechanisms between older adults’ use of CHECS and their self- reported health.Methods: The study employs the Instrumental Variable technique and empirically investigates the relationship, heterogeneity effects and influential mechanisms between older adults using CHECS and their self-reported health using data from the China Longitudinal Aging Social Survey from 2018.Results: The findings indicate, firstly, that using CHECS considerably improves older adults’ self-reported health. Secondly, the heterogeneity test reveals that the effect is more pronounced for older adults who are under the age of 80, have functional disabilities, are free of chronic diseases, have never attended school, reside in lower-income households, are single, rarely interact with their children, and live in central urban or city/county regions. Thirdly, the mechanism test reveals that the “social network effect” and “family care effect” are the key influence channels of using CHECS.Conclusion: An empirical foundation for the policy reform of community home-based care for seniors is provided by this study with the limitations to discuss the other socioeconomic aspects such as government health expenditure and discuss the specific services aspects such as health care. The findings carry substantial implications for improving the health of older individuals and provide suggestions for establishing a socialized aged care system in China.

7 March 2023 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
DLDawei Li
Dawei Li
JMJinlong Ma
Jinlong Ma
BWBaojian Wei
Baojian Wei
SGShuang Gao
Shuang Gao
YLYanmei Lang
Yanmei Lang
XWXueying Wan
Xueying Wan
Objective: To conduct a meta-analysis of the effectiveness and safety of ginkgo biloba preparations combined with donepezil hydrochloride vs. donepezil for the treatment of Alzheimer's disease (AD).Methods: Three English databases (Cochrane Library, PubMed, EMBASE), and four Chinese databases [the China National Knowledge Infrastructure (CKNI), the Chinese Biomedical Literature database (CBM), the Chongqing VIP database, and WANFANG DATA)] were manually searched for literature published from the respective dates of inception of the databases to December 2022. The randomized controlled trials (RCTs) of ginkgo biloba preparations with donepezil hydrochloride vs. donepezil for the treatment of AD were included. Relevant literature was screened, and the data in the included studies were extracted for quality assessment according to the Risk of bias tool. The RevMan 5.3 software was used for meta-analysis.Results: A total of 1,642 participants were enrolled in the 18 RCTs. Of these, 842 were in the experimental group (ginkgo biloba preparations combined with donepezil hydrochloride) and 800 were in the control group (donepezil). The overall methodological quality of the included RCTs is poor due to the high risks of blindness and allocation concealment. The meta-analysis results showed statistically significant differences in several outcomes including Risk Ratio (RR) in change for clinical effectiveness rate (1.23, 95% CI 1.13, 1.34, P < 0.00001), mean difference (MD) in change for Mini-Mental State Examination score (3.02, 95% CI 2.14, 3.89, P < 0.00001), Activity of Daily Living Scale score (−4.56, 95% CI −5.09, −4.03, P < 0.00001), Hasegawa Dementia Scale score (2.04, 95% CI 1.74, 2.34, P < 0.00001), Montreal Cognitive Assessment score (2.38, 95% CI 0.72, 4.06, P = 0.005), between the experimental and control groups. But there is no statistically significant difference in change for adverse reaction (0.91, 95% CI 0.58, 1.42, P = 0.69).Conclusion: Ginkgo biloba preparations plus donepezil can improve clinical effectiveness rate and vocabulary memory outcomes. However, more relevant high-quality RCTs are needed in the future to validate these results.Systematic review registration: Identifier CRD42022378970.

31 August 2023 in Dermatology and Therapy
Verified
Journal Article
Open access
PDF file
CZChenyang Zang
Chenyang Zang
JLJie Liu
Jie Liu
MMManyun Mao
Manyun Mao
WZWu Zhu
Wu Zhu
XCXiang Chen
Xiang Chen
BWBaojian Wei
Baojian Wei
Introduction Previous studies have proposed a possible gut–skin axis, and linked gut microbiota to psoriasis risks. However, there is heterogeneity in existing evidence. Observational research is prone to bias, and it is hard to determine causality. Therefore, this study aims to evaluate possible causal associations between gut microbiota (GM) and psoriasis. Methods With published large-scale GWAS (genome-wide association study) summary datasets, two-sample Mendelian randomization (MR) was performed to sort out possible causal roles of GM in psoriasis and arthropathic psoriasis (PsA). The inverse variance weighted (IVW) method was taken as the primary evaluation of causal association. As complements to the IVW method, we also applied MR-Egger, weighted median. Sensitivity analyses were conducted using Cochrane’s Q test, MR-Egger intercept test, MR-PRESSO (Mendelian Randomization Pleiotropy RESidual Sum and Outlier) global test, and leave-one-out analysis. Results By primary IVW analysis, we identified nominal protective roles of Bacteroidetes (odds ratio, OR 0.81, P = 0.033) and Prevotella9 (OR 0.87, P = 0.045) in psoriasis risks. Bacteroidia (OR 0.65, P = 0.03), Bacteroidales (OR 0.65, P = 0.03), and Ruminococcaceae UCG002 (OR 0.81, P = 0.038) are nominally associated with lower risks for PsA. On the other hand, Pasteurellales (OR 1.22, P = 0.033), Pasteurellaceae (OR 1.22, P = 0.033), Blautia (OR 1.46, P = 0.014), Methanobrevibacter (OR 1.27, P = 0.026), and Eubacterium fissicatena group (OR 1.21, P = 0.028) are nominal risk factors for PsA. Additionally, E. fissicatena group is a possible risk factor for psoriasis (OR 1.22, P = 0.00018). After false discovery rate (FDR) correction, E. fissicatena group remains a risk factor for psoriasis (PFDR = 0.03798). Conclusion We comprehensively evaluated possible causal associations of GM with psoriasis and arthropathic psoriasis, and identified several nominal associations. E. fissicatena group remains a risk factor for psoriasis after FDR correction. Our results offer promising therapeutic targets for psoriasis clinical management.

5 June 2025 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
SHSihan Hu
Sihan Hu
JSJiayuan Song
Jiayuan Song
HJHui Jiang
Hui Jiang
BWBaojian Wei
Baojian Wei
HWHui Wang
Hui Wang
Objective: This study targets to investigate the connection between the possibility of Cardiometabolic Multimorbidity (CMM) and the Dietary Index for Gut Microbiota (DI-GM), paying special attention to the mediating roles of systemic inflammatory markers, specifically the Systemic Immune-Inflammation Index (SII) and the Systemic Inflammatory Response Index (SIRI).Methods: A cross-sectional study was conducted involving 17,388 eligible participants from the National Health and Nutrition Examination Survey (NHANES) spanning from 2007 to 2020. Weighted logistic regression model was employed to assess the correlation between DI-GM, SII, SIRI, and CMM. Additionally, restricted cubic spline (RCS) regression model was utilized to investigate any potential nonlinear relationships between these variables and the risk of CMM. The degree to which SII and SIRI mediated the link between CMM and DI-GM was assessed using mediation analysis. Additionally, sensitivity and subgroup analyses were conducted to confirm the results.Results: A lower risk of CMM was markedly correlated with higher DI-GM scores (OR = 0.94, 95% CI: 0.91–0.98, p = 0.001). An elevated risk of CMM was markedly linked to higher levels of Ln-SII and Ln-SIRI (OR = 1.45, 95% CI: 1.28–1.65, p < 0.001; OR = 1.87, 95% CI: 1.69–2.07, p < 0.001). Higher education levels were associated with a stronger protective effect of DI-GM on CMM, according to subgroup analysis (P for interaction < 0.05). SII and SIRI, which accounted for 8.3 and 18.1% of the total effect, respectively, partially mediated the link between DI-GM and CMM (p < 0.001). Sensitivity analysis proved the stability of the findings.Conclusion: According to the study’s findings, DI-GM could mitigate the danger of CMM. Reduced systemic inflammation acted as a partial mediating factor in this connection. These findings highlight the mechanisms of gut microbiota to mitigate the danger of CMM from a nutritional perspective. This offers insightful information for clinical CMM therapy and prevention.

5 October 2023 in Frontiers in Endocrinology
Verified
Journal Article
Open access
HZHong-Yu Zhang
Hong-Yu Zhang
HYHan-Yong Yu
Han-Yong Yu
GZGuo-Xu Zhao
Guo-Xu Zhao
XJXin-Zhan Jiang
Xin-Zhan Jiang
GGGe Gao
Ge Gao
BWBaojian Wei
Baojian Wei
Background: Glioma is a prevalent and lethal brain malignancy; despite current treatment options, the prognosis remains poor. Therefore, immunotherapy has emerged as a promising therapeutic strategy. However, research trends and hotspots in glioma immunotherapy have not been systematically analyzed. This study aimed to elucidate global research trends and knowledge structures regarding immunotherapy for glioma using bibliometric analysis.Methods: Publications related to immunotherapy for glioma from 2000-2023 were retrieved from Web of Science Core Collection database (WoSCC). We conducted quantitative analysis and visualization of research trends using various tools, including VOSviewer (1.6.18), CiteSpace (5.7 R3), Microsoft Charticulator, and the Bibliometrix package in R.Results: A total of 4910 publications were included. The number of annual publications exhibited an obvious upward trend since 2019. The USA was the dominant country in terms of publication output and centrality. Frontiers in Immunology published the most articles. Harvard Medical School ranked first in productivity among institutions. Sampson, John H. Ph.D. is the most prolific author in the field with 88 articles and a total of 7055 citations. Clinical Cancer Research has the largest total number and impact factor. Analysis of keywords showed immunotherapy, glioblastoma, immunotherapy, and clinical trials as hot topics. The tumor microenvironment, cell death pathways, chimeric antigen receptor engineering, tumor-associated macrophages, and nivolumab treatment represent indicating shifts in the direction of future glioma immunotherapy development.Conclusion: This bibliometric analysis systematically delineated global landscapes and emerging trends in glioma immunotherapy research. This study highlighted the prominence of Chimeric Antigen Receptor T-cell (CAR-T), Programmed Death-1 (PD-1), and nivolumab in current glioma immunotherapy research. The growing emphasis on specific neoantigens and prognostic tumor markers suggests potential avenues for future exploration. Furthermore, the data underscores the importance of strengthened international collaboration in advancing the field.